Skip to Content
Merck
  • hucMSC Exosome-Derived GPX1 Is Required for the Recovery of Hepatic Oxidant Injury.

hucMSC Exosome-Derived GPX1 Is Required for the Recovery of Hepatic Oxidant Injury.

Molecular therapy : the journal of the American Society of Gene Therapy (2017-01-17)
Yongmin Yan, Wenqian Jiang, Youwen Tan, Shengqiang Zou, Hongguang Zhang, Fei Mao, Aihua Gong, Hui Qian, Wenrong Xu
ABSTRACT

Exosomes are small biological membrane vesicles secreted by various cells, including mesenchymal stem cells (MSCs). We previously reported that MSC-derived exosomes (MSC-Ex) can elicit hepatoprotective effects against toxicant-induced injury. However, the success of MSC-Ex-based therapy for treatment of liver diseases and the underlying mechanisms have not been well characterized. We used human umbilical cord MSC-derived exosome (hucMSC-Ex) administrated by tail vein or oral gavage at different doses and, in engrafted liver mouse models, noted antioxidant and anti-apoptotic effects and rescue from liver failure. A single systemic administration of hucMSC-Ex (16 mg/kg) effectively rescued the recipient mice from carbon tetrachloride (CCl

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Luperox® DI, tert-Butyl peroxide, 98%
Sigma-Aldrich
MISSION® esiRNA, targeting human GPX1
Sigma-Aldrich
JC-1, solid